IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
about
Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonismSIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathwaysNuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunityToll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signalingThe GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppressionIRF7: activation, regulation, modification and functionOptineurin negatively regulates the induction of IFNbeta in response to RNA virus infectionSIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanismsHepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functionsGalectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasionPositive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modificationHerpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5Emerging roles for the non-canonical IKKs in cancerViral apoptosis is induced by IRF-3-mediated activation of BaxA novel function of human Pumilio proteins in cytoplasmic sensing of viral infectionA20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoterActivation of interferon regulatory factor 5 by site specific phosphorylationGene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cellsSINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANKToll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-betaNovel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivoEvasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodiesThe tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral responseInvolvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genesNegative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinaseREUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-IEbola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionWDFY1 mediates TLR3/4 signaling by recruiting TRIFThe tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signalingCardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusHuman respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-IThe DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune responseEndotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expresThe transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3Mapping a dynamic innate immunity protein interaction network regulating type I interferon productionA TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signalingPPM1B negatively regulates antiviral response via dephosphorylating TBK1Innate immune recognition of viral infection
P2860
Q21090517-61B7E773-62DE-4FCC-9F03-DA12855079B7Q24294536-4670E52B-69A5-4D8C-9E8B-73E539932ADEQ24296410-8EA26925-617E-4BF8-8701-502A23E54293Q24296473-331159C2-F969-4072-85CB-41339E5ECCEAQ24297831-98B3981B-CC49-4C07-937C-0E7BA1835A68Q24299196-09403A2C-93DD-4651-AA7A-CEC703E27FF0Q24299740-4A72CBCC-1D4D-4337-B4AD-D004FAF0B40AQ24300481-8C8BD21B-8275-4CE9-A02C-A89CF6BE61F0Q24301289-E68EF561-5072-4913-8D89-FABE57B52144Q24301741-1CB47D4B-498A-41B8-B494-473BF5205D6AQ24301905-EBA0773B-0797-4086-A21B-1D1985117903Q24304218-B60B9142-EE81-4616-B5CE-B1896BC4A3E3Q24304261-B0E0698B-8672-448C-B918-F7AA994E779FQ24305225-CF7F3CA4-AF0B-40E5-A1C2-3BD1DE0B64D2Q24305369-F1B4833D-9899-4370-B2AD-C2CFC86E77C4Q24306232-4D432085-2F9A-4D50-B617-513913706EC6Q24306678-35E7D6BE-93AA-41E2-80F9-FC2809294A48Q24307504-9F6B8EFC-0E8A-484C-BF19-EF3CD8C0E830Q24307725-C6868A79-E7E7-402B-BC89-68919F734337Q24310727-B3E6F37E-3A97-4E54-8A76-635CEFBDC8ADQ24311833-E026E86B-1B08-4E2A-88DB-01A7C9380035Q24312071-FB165733-F2A6-4B2B-8FB1-E3BC414AAE64Q24312835-542893D3-5971-467D-99EF-6A60C5B35E77Q24314946-E72D4ECE-69CA-452A-9796-DAD9E5018C0EQ24315604-59877691-5E7C-4D94-A0D5-7202DB8808F1Q24315702-C19A2167-099F-475D-9E61-EC1889F3F8EFQ24315750-5846990F-5637-4582-9960-7382BBCAA80FQ24318342-FB23D0BF-6421-4DB5-BA35-09B2164534A5Q24318426-EFFBD389-E634-4516-AA57-214EC2715F61Q24321402-FDE7EFB2-3D51-4AC5-94DF-F342510F27ABQ24322642-39EF50F3-AFA6-44F2-8D6F-ABC6FACF186BQ24336255-55241FBA-2CFA-4992-9876-DDCDE3B84615Q24336258-86C8CCD1-22F8-4B24-B8AE-57FA76B2BA66Q24336273-D07CFBAE-F51F-47B6-9B02-5D6DFAB9A354Q24336505-9B2DCB92-2F30-467A-B612-9DF940072B26Q24336528-9D357BEA-C018-476B-B63A-01DEAD2EFC78Q24337463-4A62D089-1EB7-4016-A136-FF553C2C5BDAQ24337616-E2DF1C73-F3C0-47C6-9057-2C27D341E7E5Q24339402-374F1D54-1C42-4D7C-AD9E-7581A72D7436Q24498364-1C02F6A1-8CF8-4017-BEDD-DCFED30161F7
P2860
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@ast
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@en
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@nl
type
label
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@ast
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@en
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@nl
prefLabel
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@ast
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@en
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@nl
P2093
P3181
P356
P1433
P1476
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway
@en
P2093
Anthony J Coyle
Daniel C Rowe
Douglas T Golenbock
Katherine A Fitzgerald
Kerrie L Faia
Sarah M McWhirter
Sha-Mei Liao
P3181
P356
10.1038/NI921
P407
P577
2003-05-01T00:00:00Z